Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutininLarry Smith, Ronald B. Moss, Souphaphone Boutsaboualoy et al.|Vaccine|2010Cited by 142
DAS181 for Treatment of Parainfluenza Virus Infections in Hematopoietic Stem Cell Transplant Recipients at a Single CenterMirella Salvatore, Rosemary Soave, Michael J. Satlin et al.|Transplantation and Cellular Therapy|2016Cited by 64